home / stock / eyen / eyen articles

EYEN Articles, Eyenovia Inc. - From 05/21/24

Stock Information
Company Name: Eyenovia Inc.
Stock Symbol: EYEN
Market: NASDAQ
Website: eyenovia.com
Menu
EYEN EYEN Quote EYEN Short EYEN News EYEN Articles EYEN Message Board
Get EYEN Alerts

News, Short Squeeze, Breakout and More Instantly...
All You Need to Know About Eyenovia Rating Upgrade to Buy | Benzinga

Eyenovia, Inc. (NASDAQ: EYEN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially...
Crude Oil Moves Higher; Deere Cuts Profit Outlook | Benzinga

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.1% on Thursday. The Dow traded up 0.01% to 39,912.06...

Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Fluent Inc (NASDAQ:FLNT) fell sharply during Thursday's session after posting weaker-than-expected quarterly results. Fluent posted ...

Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th | Benzinga

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), an ophthalmic company with two FDA-approved products and a late-stage a...
Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying | Benzinga

The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern ...

Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th | Benzinga

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic pharmaceutical technology company, toda...

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quar...
Beyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, Inflammation | Benzinga

Taiwan-based Formosa Pharmaceuticals and AimMax Therapeutics announced Monday that the FDA approved clobetasol propionate ophth...

Insiders Buying Eyenovia And 3 Other Stocks Under $2 | Benzinga

The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around t...

Eyenovia's Stock Is Soaring Today - Here's Why | Benzinga

William Blair initiated coverage on Eyenovia Inc (NASDAQ: EYEN), a biopharma company focused on developing therapies based on its Op...
Previous 10 Next 10